Gladstone President Deepak Srivastava moderated a conversation with Jennifer Doudna and Shinya Yamanaka to discuss the potential impact of CRISPR and iPS cells over the coming decade and hear from the two world-class scientists about how they plan to shape the enormous opportunities that lie ahead.
Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012 for his discovery of induced pluripotent stem cells (iPS cells). And last year, Doudna received the Nobel Prize in Chemistry for her co-discovery of the CRISPR-Cas9 gene-editing technology. Arguably the two most impactful advances of this century, the discoveries by these Gladstone investigators are now accelerating our understanding and treatment of human disease at an unprecedented pace.
Support Discovery Science
Your gift to Gladstone will allow our researchers to pursue high-quality science, focus on disease, and train the next generation of scientific thought leaders.
New CRISPR-Based Test for COVID-19 Uses a Smartphone Camera
Article
December 4, 2020
New CRISPR-Based Test for COVID-19 Uses a Smartphone Camera
The rapid, one-step mobile test could help combat the pandemic and fully reopen communities
News Release COVID-19 Data Science and Biotechnology Virology Doudna Lab Ott Lab CRISPR/Gene EditingGladstone Investigator Jennifer Doudna Wins Nobel Prize in Chemistry
Article
October 7, 2020
Gladstone Investigator Jennifer Doudna Wins Nobel Prize in Chemistry
Doudna’s discovery of the CRISPR-Cas9 system revolutionized biomedical research
Awards News Release Data Science and Biotechnology Virology Doudna Lab CRISPR/Gene EditingFrom HIV to COVID-19
Article
April 24, 2020
From HIV to COVID-19
Researchers who spent decades studying human immunodeficiency virus are using some of the same tools and approaches to tackle SARS-CoV-2, the virus that causes COVID-19.
Gladstone Experts COVID-19 HIV/AIDS Center for HIV Cure Research Virology Akassoglou Lab Doudna Lab Greene Lab Ott Lab